Abacus Life
ABL

$10.04

0.6%

Market Cap: $749M

About: Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.

Employees: 102

Financials Investment Advice

0

Funds holding %

of 6,686 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

2,153% more capital invested

Capital invested by funds: $4.31M [Q1] → $97.1M (+$92.8M) [Q2]

967% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 3

193% more funds holding

Funds holding: 15 [Q1] → 44 (+29) [Q2]

14.36% more ownership

Funds ownership: 0.56% [Q1] → 14.92% (+14.36%) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$12

20%

upside

Avg. target

$14.25

42%

upside

High target

$16

59%

upside

4 analyst ratings

4 positive

100%

0 neutral

0%

0 negative

0%

B. Riley Securities Matt Howlett 50% 1-year accuracy 10 / 20 met price target	59%upside $16	Buy Reiterated	29 Aug 2024
TD Cowen Andrew Kilgerman 100% 1-year accuracy 2 / 2 met price target	39%upside $14	Buy Initiated	7 Aug 2024
Piper Sandler Crispin Love 40% 1-year accuracy 10 / 25 met price target	20%upside $12	Overweight Initiated	26 Jun 2024
B. Riley Securities Matt Howlett 50% 1-year accuracy 10 / 20 met price target	49%upside $15	Buy Reiterated	24 Jun 2024

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about ABL published over the past 30 days

Zacks Investment Research

Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?

Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?

Zacks Investment Research

Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know

The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know

Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions

ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, and Lorisco Life LLC (“Lorisco”), a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.

Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions

Abacus Life, Inc. (ABL) Q2 2024 Earnings Call Transcript

Abacus Life, Inc. (NASDAQ:ABL ) Q2 2024 Earnings Conference Call August 12, 2024 9:00 AM ET Company Participants Garrett Edson - Managing Director ICR Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Crispin Love - Piper Sandler Andrew Kligerman - TD Securities Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call.

Abacus Life, Inc. (ABL) Q2 2024 Earnings Call Transcript

Abacus Life Reports Second Quarter 2024 Results

- Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Grows 83% Year-over-Year to $16.7 Million - ORLANDO, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the second quarter ended June 30, 2024.

Abacus Life Reports Second Quarter 2024 Results

Zacks Investment Research

Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?

Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?

Abacus Life Provides Preliminary Second Quarter 2024 Results

- Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17.0 Million; Grows 64-86% Year-over-Year - - Schedules Second Quarter 2024 Earnings Release and Conference Call for Monday, August 12, 2024 - ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced preliminary unaudited financial results for the second quarter ended June 30, 2024.

Abacus Life Provides Preliminary Second Quarter 2024 Results

Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA

Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA (“Carlisle”), a leading Luxembourg-based investment manager in the life settlement space, for approximately $200 million.

Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA

Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock

ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $92 million.

Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock

Why Is Abacus Life (ABL) Stock Down 18% Today?

Abacus Life (NASDAQ: ABL ) stock is falling on Friday after the alternative asset manager and market maker announced the pricing of a public offering for its shares. Abacus Life is selling 10 million shares of ABL stock for $8 each.

Why Is Abacus Life (ABL) Stock Down 18% Today?

See News Rankings